Cargando…

Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer

BACKGROUND: The aim of this study was to systematically evaluate the prognostic role of pretreatment lactate dehydrogenase (LDH) concentration for survival in patients with lung cancer through performing a meta-analysis. METHODS: PubMed, EMBASE, Cochrane Library, Web of Science, and China National K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Taibing, Zhang, Jing, Meng, Yu, Zhou, Yongzhao, Li, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160201/ https://www.ncbi.nlm.nih.gov/pubmed/30235773 http://dx.doi.org/10.1097/MD.0000000000012524

Ejemplares similares

CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma
por: Zhang, Sen, et al.
Publicado: (2022)

Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L
por: Liu, Rujiao, et al.
Publicado: (2016)

Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival
por: Kiba, Takayoshi, et al.
Publicado: (2014)

Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
por: Wang, Yu‐Hung, et al.
Publicado: (2022)

Prognostic significance of pretreatment serum lactate dehydrogenase-to-albumin ratio in gastric cancer
por: Aday, Ulaş, et al.
Publicado: (2020)

Varying postresection lactate dehydrogenase with overall survival of early stage pancreatic cancer patients: A retrospective study
por: Xiao, Yuanyuan, et al.
Publicado: (2017)

Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2022)

Wnt3a protein overexpression predicts worse overall survival in laryngeal squamous cell carcinoma
por: Zhang, Diekuo, et al.
Publicado: (2019)

Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement
por: Gao, Qiongqiong, et al.
Publicado: (2017)

Serum lactate dehydrogenase and survival following cancer diagnosis
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Pretreatment Neutrophil-to-Lymphocyte Ratio and Lactate Dehydrogenase Predict the Prognosis of Metastatic Cervical Cancer Treated with Combination Immunotherapy
por: Cheng, Mingxia, et al.
Publicado: (2022)

Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer
por: Bando, Etsuro, et al.
Publicado: (2020)

Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
por: Franzke, A., et al.
Publicado: (1998)

Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma
por: Zhao, Mingkun, et al.
Publicado: (2022)

Higher Plasma Fibrinogen Levels are Associated with Malignant Phenotype and Worse Survival in Patients with Glioblastomas
por: Wang, Peng-Fei, et al.
Publicado: (2018)

Low expression of CIP4 in predicting worse overall survival: A potential biomarker for laryngeal cancer
por: Fang, Lucheng, et al.
Publicado: (2021)

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
por: Chen, Zhan, et al.
Publicado: (2022)

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2016)

LncRNA SNHG1 correlates with higher T stage and worse overall survival, and promotes cell proliferation while reduces cell apoptosis in breast cancer
por: Sun, Lin, et al.
Publicado: (2019)

Nomograms based on lactate dehydrogenase to albumin ratio for predicting survival in colorectal cancer
por: Hu, Yugang, et al.
Publicado: (2022)

Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
por: Li, Wanwan, et al.
Publicado: (2019)

Higher Serum Levels of Lactate Dehydrogenase Before Microsurgery Predict Poor Outcome of Aneurysmal Subarachnoid Hemorrhage
por: Zheng, Shufa, et al.
Publicado: (2021)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma
por: Zhou, Jiayu, et al.
Publicado: (2018)

Pretreatment lactate dehydrogenase may predict outcome of advanced non small‐cell lung cancer patients treated with immune checkpoint inhibitors: A meta‐analysis
por: Zhang, Zhibo, et al.
Publicado: (2019)

Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy
por: He, Man, et al.
Publicado: (2021)

Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma: A meta-analysis
por: Zhuo, Yi, et al.
Publicado: (2016)

CT‐determined low skeletal muscle mass predicts worse overall survival of gastric cancer in patients with cachexia
por: Wan, Qianyi, et al.
Publicado: (2022)

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617
por: Jin, Jian-Yue, et al.
Publicado: (2021)

Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer
por: Minami, Seigo, et al.
Publicado: (2017)

Predictive value of pretreatment albumin‐to‐alkaline phosphatase ratio for overall survival for patients with advanced non‐small cell lung cancer
por: Zhou, Shaozhang, et al.
Publicado: (2020)

Systemic inflammatory markers and serum lactate dehydrogenase predict survival in patients with Wilms tumour
por: Kunc, Michał, et al.
Publicado: (2021)

Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer
por: Zhang, Wenna, et al.
Publicado: (2015)

Lactate dehydrogenase predicting mortality in patients with aneurysmal subarachnoid hemorrhage
por: Zan, Xin, et al.
Publicado: (2022)

Molecular cloing and bioinformatics analysis of lactate dehydrogenase from Taenia multiceps
por: Guo, Cheng, et al.
Publicado: (2017)

Pretreatment Serum Lactate Dehydrogenase Level as an Independent Prognostic Factor of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era
por: Chen, Zhuhong, et al.
Publicado: (2017)

Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis
por: Zhang, Mingwei, et al.
Publicado: (2016)

Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis
por: Zhang, Jiao, et al.
Publicado: (2015)

Pretreatment Serum Lactate Dehydrogenase and Metastases Numbers as Potential Determinants of Anti-PD-1 Therapy Outcome in Nasopharyngeal Carcinoma
por: Ali, Wael A. S., et al.
Publicado: (2023)

Lactate Dehydrogenase-Elevating Virus
por: Coutelier, Jean-Paul, et al.
Publicado: (2007)

Lactate Dehydrogenase: The Beacon of Hope?
por: Pandarathodiyil, Anitha Krishnan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1mbbu1jui93muk5rimchg9mvr